Actively Recruiting
Impact of Virtual Reality on the Quality of Life of Oncology Patients
Led by Central Hospital Saint Quentin · Updated on 2024-07-03
150
Participants Needed
2
Research Sites
147 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Anxiety, nausea and vomiting are common side effects in paediatric patients receiving chemotherapy. chemotherapy. New evidence supports the efficacy of immersive virtual reality in improving symptoms of anxiety and distress, including nausea and vomiting, in this vulnerable group. This research will evaluate the efficacy of virtual reality in managing anxiety, nausea and vomiting in cancer patients receiving their first line of chemotherapy and will also measure the quality of life of these patients and evaluate patient and nursing staff satisfaction
CONDITIONS
Official Title
Impact of Virtual Reality on the Quality of Life of Oncology Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Chemotherapy-naive patient
- Patient with first-line indication for intravenous cyclic chemotherapy
- Affiliated to a social security system
- Received full information and given free, informed, and written consent signed by participant and investigator
- Patient understands French or English
- Expected duration of chemotherapy session for the first 3 cycles greater than 30 minutes
You will not qualify if you...
- Communication disorders preventing informed consent
- Under legal protection (guardianship, curatorship, safeguard of justice)
- Epilepsy
- Severe visual or hearing impairment preventing use of headphones
- Psychiatric disorders such as delusional disorders, hallucinations, or schizophrenia
- Infections or facial wounds
- Severe claustrophobia
- Presence of pacemakers
- Known cognitive or learning problems
- Brain tumors or metastases
- Motion sickness
- Expected duration of chemotherapy session for the first 3 cycles of 30 minutes or less
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Centre Hospitalier de Chauny
Chauny, France, 02300
Actively Recruiting
2
Centre Hospitalier de Saint Quentin
Saint-Quentin, France, 02100
Actively Recruiting
Research Team
F
Frédérique Mm Roussel
CONTACT
A
Abdelkrim Mr Boulanouar
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here